Health ❯ Healthcare ❯ Clinical Trials
Immunotherapy Head and Neck Cancer Multiple Myeloma Melanoma Pancreatic Cancer Breast Cancer Drug Development Precision Medicine Follicular Lymphoma Biliary Tract Cancer Real-Time Clinical Trials Metastatic Colorectal Cancer Patient Outcomes Chronic Myeloid Leukemia Treatment Options Enzalutamide Therapy Late-Stage Trials Radiopharmaceuticals Glioblastoma Small Lymphocytic Lymphoma Combination Therapies Neurofibromatosis Chemotherapy Diffuse Large B-Cell Lymphoma Autoimmunity Lung Cancer Research Lymphoma Lung Cancer Chronic Lymphocytic Leukaemia Melanoma Treatment Gastroesophageal Cancer Hepatocellular Carcinoma Bispecific Monoclonal Antibodies Cancer Treatments Renal Cell Carcinoma Chronic Lymphocytic Leukemia Prostate Cancer Myeloproliferative Neoplasms Survival Rates Phase 3 Trials Colorectal Cancer Gastroesophageal Adenocarcinoma Metastatic Uveal Melanoma Non-Small Cell Lung Cancer B-cell Malignancies Myelofibrosis Gastrointestinal Cancer
The China-only study reported a statistically significant overall survival gain but also higher rates of bleeding and serious adverse events, leaving regulators and investors to await global trial data to judge wider use.
